Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents
Mohamed Hisham, Bahaa G. M. Youssif, Essam Eldin A. Osman, et al.
European Journal of Medicinal Chemistry (2019) Vol. 176, pp. 117-128
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Cellular Red-Ox system in health and disease: The latest update
Atala Bihari Jena, Rashmi Rekha Samal, Nitish Kumar Bhol, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114606-114606
Open Access | Times Cited: 211
Imidazoles as Potential Anticancer Agents: An Update on Recent Studies
Pankaj Sharma, Chris LaRosa, Janet Antwi, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4213-4213
Open Access | Times Cited: 122
Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid, et al.
Bioorganic Chemistry (2020) Vol. 106, pp. 104510-104510
Closed Access | Times Cited: 85
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
Osama M. Soltan, Mai E. Shoman, Salah A. Abdel‐Aziz, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113768-113768
Closed Access | Times Cited: 85
Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity
Fatma A. Mohamed, Hesham A. M. Gomaa, Omnia M. Hendawy, et al.
Bioorganic Chemistry (2021) Vol. 112, pp. 104960-104960
Closed Access | Times Cited: 59
Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities
Hesham A. M. Gomaa, Mohamed E. Shaker, Sami I. Alzarea, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105616-105616
Closed Access | Times Cited: 44
Discovery of new pyrimido[5,4-c]quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies
Ramadan Ahmed Mekheimer, Samar M R Allam, Mariam A. Al‐Sheikh, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105693-105693
Closed Access | Times Cited: 39
Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors
Lamya H. Al-Wahaibi, Ahmed M. Gouda, Ola F. Abou‐Ghadir, et al.
Bioorganic Chemistry (2020) Vol. 104, pp. 104260-104260
Closed Access | Times Cited: 62
Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
Chris A. Brosey, Jerry H. Houl, Panagiotis Katsonis, et al.
Progress in Biophysics and Molecular Biology (2021) Vol. 163, pp. 171-186
Open Access | Times Cited: 53
Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV
Heba A. Hofny, Mamdouh F. A. Mohamed, Hesham A. M. Gomaa, et al.
Bioorganic Chemistry (2021) Vol. 112, pp. 104920-104920
Closed Access | Times Cited: 52
Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile
Salah A. Abdel‐Aziz, Ehab S. Taher, Ping Lan, et al.
Bioorganic Chemistry (2021) Vol. 111, pp. 104890-104890
Closed Access | Times Cited: 47
Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity
Heba S. A. Elzahabi, Mohamed S. Nafie, Dina A. Osman, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113609-113609
Closed Access | Times Cited: 45
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 35
Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors
Mohamed Hisham, Heba A. Hassan, Hesham A. M. Gomaa, et al.
Journal of Molecular Structure (2022) Vol. 1254, pp. 132422-132422
Closed Access | Times Cited: 33
Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 376-386
Open Access | Times Cited: 27
Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR/HER2 target inhibition
Mostafa E. Salem, Esraa M. Mahrous, Eman A. Ragab, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Synthesis and biological assessment of indole derivatives containing penta-heterocycles scaffold as novel anticancer agents towards A549 and K562 cells
Guanglong Zhang, Zhenhua Tang, Sili Fan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 15
Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis–Pyrazoline Derivatives as Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Eman A. M. Beshr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9104-9104
Open Access | Times Cited: 15
Epidermal Growth Factor Receptors Unveiled: A Comprehensive Survey on Mutations, Clinical Insights of Global Inhibitors, and Emergence of Heterocyclic Derivatives as EGFR Inhibitors
Chandramouli Manojmouli, T. Y. Pasha, Mohamed Rahamathulla, et al.
Journal of drug targeting (2025), pp. 1-19
Closed Access
Potent EGFR/PARP-1 inhibition by spirooxindole-triazole hybrids for targeted liver cancer therapy
Mohamed S. Nafie, M. Ali, Moayad Abdullah Alwehaibi, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 58-74
Open Access
Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation
Adel A. Marzouk, Salah A. Abdel‐Aziz, Kamal Abdelrahman, et al.
Bioorganic Chemistry (2020) Vol. 102, pp. 104090-104090
Closed Access | Times Cited: 45
Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity
Hesham A. M. Gomaa, Hany A.M. El-Sherief, Shaimaa Hussein, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104369-104369
Closed Access | Times Cited: 41
Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity
Bahaa G. M. Youssif, Ahmed M. Gouda, Amr H. Moustafa, et al.
Journal of Molecular Structure (2021) Vol. 1253, pp. 132218-132218
Closed Access | Times Cited: 38
Quinoline‐based thiazolidinone derivatives as potent cytotoxic and apoptosis‐inducing agents through EGFR inhibition
Mohamed S. Nafie, Safaa M. Kishk, Sebaey Mahgoub, et al.
Chemical Biology & Drug Design (2021) Vol. 99, Iss. 4, pp. 547-560
Closed Access | Times Cited: 32
Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
Lamya H. Al-Wahaibi, Yaser A. Mostafa, Mostafa Abdelrahman, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1006-1006
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top